Skip to content
MusclePharm Gets Slammed Back Down to Unprofitable Performance  episode artwork

Aug 24, 2021 16 min

MusclePharm Gets Slammed Back Down to Unprofitable Performance

from the Joshua Schall Audio Experience Hosted by Joshua Schall

Just when MusclePharm had profitability on its mind, the sports nutrition company gets slammed back down to face its historical reality. In this episode, I'll provide you with various insights pulled from the MusclePharm (OTCMKTS: MSLP) 2021Q2 earnings report, earnings call, and additional publicly-disclosed information released by the company. They will collectively be used to update you on the sales performance and profitability plan of action at MusclePharm. I will also provide an extensive update on the energy drinks project that includes MP Performance Energy and FitMiss. This includes a longer term outlook on segment-level revenue expectation and details of categorical challenges and potential land mines. Finally, I will express my confusion on the MusclePharm energy drink instead of the Combat protein RTD beverage strategy.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

MusclePharm Gets Slammed Back Down to Unprofitable Performance

0:00 16:54

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of the Joshua Schall Audio Experience?

This episode is 16 minutes long.

When was this the Joshua Schall Audio Experience episode published?

This episode was published on August 24, 2021.

Can I download this the Joshua Schall Audio Experience episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.